148 related articles for article (PubMed ID: 12022265)
1. A proposal to solve the comparability problem in cost-utility analysis.
Bleichrodt H; Herrero C; Pinto JL
J Health Econ; 2002 May; 21(3):397-403. PubMed ID: 12022265
[TBL] [Abstract][Full Text] [Related]
2. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
Donaldson C; Birch S; Gafni A
Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
[TBL] [Abstract][Full Text] [Related]
3. Valuing health states: a comparison of methods.
Dolan P; Gudex C; Kind P; Williams A
J Health Econ; 1996 Apr; 15(2):209-31. PubMed ID: 10159110
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation in health care: is there a role for cost-benefit analysis?
Johannesson M; Jönsson B
Health Policy; 1991 Feb; 17(1):1-23. PubMed ID: 10113574
[TBL] [Abstract][Full Text] [Related]
5. Outcome measurement in economic evaluation.
Johannesson M; Jönsson B; Karlsson G
Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
[No Abstract] [Full Text] [Related]
6. Cost-utility analysis from a societal perspective.
Johannesson M; O'Conor RM
Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
[TBL] [Abstract][Full Text] [Related]
7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
8. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?
Bleichrodt H; Quiggin J
J Health Econ; 1999 Dec; 18(6):681-708. PubMed ID: 10847930
[TBL] [Abstract][Full Text] [Related]
9. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group.
Weinstein MC; Siegel JE; Garber AM; Lipscomb J; Luce BR; Manning WG; Torrance GW
Health Econ; 1997; 6(5):505-10. PubMed ID: 9353651
[No Abstract] [Full Text] [Related]
10. A review of the use of health status measures in economic evaluation.
Brazier J; Deverill M; Green C; Harper R; Booth A
Health Technol Assess; 1999; 3(9):i-iv, 1-164. PubMed ID: 10392311
[No Abstract] [Full Text] [Related]
11. The missing link: on the line between C and E.
Brouwer WB; Rutten FF
Health Econ; 2003 Aug; 12(8):629-36. PubMed ID: 12898661
[TBL] [Abstract][Full Text] [Related]
12. Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?
Brinsmead R; Hill S
J Clin Pharm Ther; 2003 Aug; 28(4):339-46. PubMed ID: 12911687
[TBL] [Abstract][Full Text] [Related]
13. A second opinion. Cost-utility analysis and varying preferences for health.
Mooney G; Jan S
Health Policy; 1997 Sep; 41(3):201-3; discussion 203-5. PubMed ID: 10170089
[No Abstract] [Full Text] [Related]
14. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
Bleichrodt H
Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
[TBL] [Abstract][Full Text] [Related]
15. Toward consistency in cost-utility analyses: using national measures to create condition-specific values.
Gold MR; Franks P; McCoy KI; Fryback DG
Med Care; 1998 Jun; 36(6):778-92. PubMed ID: 9630120
[TBL] [Abstract][Full Text] [Related]
16. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
Oliver A
Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis studies of depression management: a systematic review.
Pirraglia PA; Rosen AB; Hermann RC; Olchanski NV; Neumann P
Am J Psychiatry; 2004 Dec; 161(12):2155-62. PubMed ID: 15569883
[TBL] [Abstract][Full Text] [Related]
18. A further examination of the problem of double-counting in incremental cost-utility analyses.
Ungar WJ
Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):333-5. PubMed ID: 27113196
[No Abstract] [Full Text] [Related]
19. 'Is there a case for using visual analogue scale valuations in CUA' by Parkin and Devlin. A response: 'yes there is a case, but what does it add to ordinal data?'.
Brazier J; McCabe C
Health Econ; 2007 Jun; 16(6):645-7; discussion 649-51. PubMed ID: 17535007
[No Abstract] [Full Text] [Related]
20. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
Gafni A
Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
